Oyan, B. Et Al. 2004. Does letrozole have any place in adjuvant setting in breast cancer patients with documented hypercoagulability?. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.27, no.2 , 210-211.

Oyan, B., Altundag, K., & Ozisik, Y., (2004). Does letrozole have any place in adjuvant setting in breast cancer patients with documented hypercoagulability?. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.27, no.2, 210-211.

Oyan, B, K Altundag, And Y Ozisik. "Does letrozole have any place in adjuvant setting in breast cancer patients with documented hypercoagulability?," AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.27, no.2, 210-211, 2004

Oyan, B Et Al. "Does letrozole have any place in adjuvant setting in breast cancer patients with documented hypercoagulability?." AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.27, no.2, pp.210-211, 2004

Oyan, B. Altundag, K. And Ozisik, Y. (2004) . "Does letrozole have any place in adjuvant setting in breast cancer patients with documented hypercoagulability?." AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.27, no.2, pp.210-211.

@article{article, author={B Oyan Et Al. }, title={Does letrozole have any place in adjuvant setting in breast cancer patients with documented hypercoagulability?}, journal={AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS}, year=2004, pages={210-211} }